Country: Ireland
Bahasa: Inggeris
Sumber: HPRA (Health Products Regulatory Authority)
CIPROFLOXACIN HYDROCHLORIDE
PCO Manufacturing
CIPROFLOXACIN HYDROCHLORIDE
250 Base Milligrams
Film Coated Tablet
Withdrawn
0000-00-00
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ciproxin 250 mg Film-coated Tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 250 mg ciprofloxacin (as hydrochloride). For full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. _Product imported from Hungary:_ White, round tablets with Bayer cross impressed on one side and ‘CIP’, a breakline and ‘250’ impressed on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ciprofloxacin is indicated for the treatment of the following infections caused by sensitive bacteria: _Adults:_ Respiratory tract infections: e.g. lobar and bronchopneumonia, acute and chronic bronchitis, acute exacerbation of cystic fibrosis, bronchiectasis, empysema. Ciprofloxacin is not recommended as first-line therapy for the treatment of pneumococcal pneumonia. In circumstances where a physician considers it appropriate to use ciprofloxacin in patients with pneumococcal pneumonia, a dose of 750mg twice daily should provide adequate cover in the majority of cases _(see Dosage and Administration section). _Ciprofloxacin may be used for treating Gram-negative pneumonia. _Urinary tract infections:_e.g. uncomplicated and complicated urethritis, cystitis, pyelonephritis, prostatitis, epididymitis. _Gastro-intestinal infections: _e.g. enteric fever, infective diarrhoea. _Gonorrhoea: _including urethral, rectal and pharyngeal gonorrhoea caused by ß-lactamase producing organisms or organisms moderately sensitive to penicillin. _Children:_ For the treatment of acute pulmonary exacerbation of cystic fibrosis associated with P. aeruginosa infection in paediatric patients aged 5-17 years. Inhalation Anthrax in Adults and Children: to reduced the incidence or progression of disease following confirmed or suspected ex Baca dokumen lengkap